Syringe Distribution to Injection Drug Users for Prevention of HIV Infection: Opinions and Practices of Health Care Providers in New York City

Clinical Infectious Diseases

Volumn 38, Issue 3, 2004, Pages 438-441

  Coffin, Phillip O ^a,b,c   Fuller, Crystal ^a   Blaney, Shannon ^a   Vadnai, Liza ^a   Miller, Sarah ^a   Vlahov, David ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LAW; LEGAL ASPECT; MALE; MEDICAL PRACTICE; MORALITY; NORMAL HUMAN; NURSE; PHYSICIAN; PRIORITY JOURNAL; SELF INJECTION; SYRINGE;

EID: 1042288565     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/381095     Document Type: Article

References (18)

1. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996; 348:987-91.
2. Normand J, Vlahov D, Moses LE, eds. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy of Medicine, 1995.
3. New York City Department of Health HIV/AIDS Surveillance Program. Semi-annual report with estimates of persons living with AIDS in New York City. New York: New York City Department of Health, 2002.
4. Strasfeld L, Lo Y, Netski D, Thomas DL, Klein RS. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr 2003; 33:356-64.
5. Des Jarlais DC, Diaz T, Perils T, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol 2003; 157:467-71.
6. Holmberg S. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996; 86:642-54.
7. Des Jarlais DC, Marmor M, Friedman P, et al. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health 2000; 90:352-9.
8. New York City Department of Health and Mental Hygiene. HIV Surveillance and Epidemiology Program: quarterly report. New York: New York City Department of Health and Mental Hygiene, 2003.
9. Moatti JP, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. Eur Addict Res 2001; 7:40-5.
10. National Commission on Acquired Immune Deficiency Syndrome. The twin epidemics of substance use and HIV. Washington, DC: National Commission on Acquired Immune Deficiency Syndrome, 1991.
11. Lurie P, Reingold A. The public health impact of needle exchange programs in the United States and abroad [prepared for the Centers for Disease Control and Prevention]. Berkeley: University of California, School of Public Health; and San Francisco: University of California, Institute for Health Policy Studies, 1993.
12. Office of Technology Assessment. The effectiveness of AIDS prevention efforts. Washington, DC: US Government Printing Office, 1995.
13. Klein SJ, Estel GR, Candelas AR, Plavin HA. Promoting safe syringe disposal goes "hand in hand" with expanded syringe access in New York State. J Am Pharm Assoc 2002; 42(Suppl 2):S105-7.
14. Klein SJ, Candelas AR, Birkhead GS. Mobilizing public and private partners to support New York's Expanded Syringe Access Demonstration Program. J Am Pharm Assoc 2002; 42(Suppl 2):S28-9.
15. Fuller CM, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc 2002; 42(Suppl 2):S77-82.
16. Rich JD, Whitlock TL, Towe CW, et al. Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island. Subst Use Misuse 2001; 36:535-50.
17. Rich JD, Macalino GE, McKenzie M, Taylor LE, Burris S. Syringe prescription to prevent HIV infection in Rhode Island: a case study. Am J Public Health 2001; 91:699-700.
18. Burris S, Vernick JS, Ditzler A, Strathdee S. The legality of selling or giving syringes to injection drug users. J Am Pharm Assoc 2002; 42(Suppl 2):S13-8.